Literature DB >> 15947646

The impact of age, body mass index and testosterone on erectile dysfunction.

Christian W Kratzik1, Georg Schatzl, Gerhard Lunglmayr, Ernst Rücklinger, Johannes Huber.   

Abstract

PURPOSE: Erectile dysfunction (ED) may be associated with low serum total testosterone (T), low serum bioavailable testosterone (BAT) and high body mass index (BMI) in aging men.
MATERIALS AND METHODS: A total of 675 workers (age range 45 to 60 years old) were entered into this study. Investigations were performed directly at their place of work. Exclusion criteria were abnormal urogenital status, antihypertensive drugs, medication possibly affecting the endocrine function and a history of previous pelvic trauma. T and sex hormone-binding globulin were measured with commercially available assays, and BAT was calculated from T and sex hormone-binding globulin. BMI was assessed and every individual completed a self-administrated questionnaire for erectile function (International Index of Erectile Function [IIEF-5]).
RESULTS: T and BAT showed a significantly negative correlation with age and BMI. Each additional year of increase in age caused a decrease in the IIEF-5 score of 0.195 (p <0.001). Increase in BMI by 1 kg/m reduced IIEF-5 by 0.141, independent of age (p =0.005). Multiple logistic regression analyses confirmed the influence of increased age and higher BMI on the risk of ED. The corresponding odds ratio for ED was 1.082 (p <0.001) and 1.076 (p <0.001), respectively. These data indicate an increase in ED risk by 8.2% per year and by 7.6% per kg/m BMI. Severe cases of ED (IIEF-5 score 7 or less) were significantly associated with a decrease in T and BAT. Individuals with low BAT (1 ng/ml or less) had a 3 times higher risk of severe ED compared with men with BAT greater than 1 ng/ml (odds ratio 3.045, 95% CI 1.088 to 8.522, p =0.034). The result of the multiple logistic regression analysis was adjusted to age and BMI, and did not show a significant influence on the incidence of severe ED.
CONCLUSIONS: BMI contributes strongly to ED. Low T or BAT are only relevant if IIEF-5 questionnaire results in severe ED.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15947646     DOI: 10.1097/01.ju.0000162049.95483.51

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

1.  The connection between type 2 diabetes and erectile dysfunction in Taiwanese aboriginal males.

Authors:  M-D Shi; J-K Chao; M-C Ma; S-K Chiang; I-C Chao
Journal:  Int J Impot Res       Date:  2014-07-31       Impact factor: 2.896

Review 2.  Radiation dose-volume effects and the penile bulb.

Authors:  Mack Roach; Jiho Nam; Giovanna Gagliardi; Issam El Naqa; Joseph O Deasy; Lawrence B Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

Review 3.  Impact of androgen deprivation therapy on sexual function.

Authors:  Clarisse R Mazzola; John P Mulhall
Journal:  Asian J Androl       Date:  2012-01-09       Impact factor: 3.285

4.  Epinephrine is associated with both erectile dysfunction and lower urinary tract symptoms.

Authors:  J C Trussell; Allen R Kunselman; Richard S Legro
Journal:  Fertil Steril       Date:  2008-12-04       Impact factor: 7.329

Review 5.  The role of nitric oxide in erectile dysfunction: implications for medical therapy.

Authors:  Arthur L Burnett
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-12       Impact factor: 3.738

6.  A meta-regression evaluating the effectiveness and prognostic factors of oral phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction.

Authors:  Jin-Qiu Yuan; Chen Mao; Zu-Yao Yang; Xiao-Hong Fu; Samuel Y Wong; Jin-Ling Tang
Journal:  Asian J Androl       Date:  2016 Jan-Feb       Impact factor: 3.285

7.  Highlight on Engineering Mycobacterium smegmatis for testosterone production.

Authors:  Utkarsh Sood; Yogendra Singh; Mallikarjun Shakarad; Rup Lal
Journal:  Microb Biotechnol       Date:  2016-12-05       Impact factor: 5.813

8.  Comparison of Sexual Function and Serum Testosterone Levels in Men Opiate Addicts, under Methadone Maintenance Therapy, and Healthy Men.

Authors:  Parvin Agha-Mohammadhasani; Mohammadreza Mokhtaree; Alireza Nazari; Amir Rahnama
Journal:  Addict Health       Date:  2018-04

Review 9.  Testosterone for the aging male; current evidence and recommended practice.

Authors:  Roger D Stanworth; T Hugh Jones
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.